These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10755481)

  • 1. From the Food and Drug Administration.
    JAMA; 2000 Apr; 283(13):1679. PubMed ID: 10755481
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
    Rubinstein E
    J Antimicrob Chemother; 2003 May; 51(5):1307-8; author reply 1308-9. PubMed ID: 12697636
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Zhanel GG; Hoban DJ; Chan CK
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102063
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia.
    Anderson KB; Tan JS; File TM; DiPersio JR; Willey BM; Low DE
    Clin Infect Dis; 2003 Aug; 37(3):376-81. PubMed ID: 12884162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson R; Cavalcanti R; Brunton JL; Bast DJ; de Azavedo JC; Kibsey P; Fleming C; Low DE
    N Engl J Med; 2002 Mar; 346(10):747-50. PubMed ID: 11882730
    [No Abstract]   [Full Text] [Related]  

  • 7. [New quinolones for the treatment of community-acquired pneumonia--pro].
    Zimmerli S
    Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
    [No Abstract]   [Full Text] [Related]  

  • 8. [New quinolones for the treatment of community-acquired pneumonia--contra].
    Egger M
    Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
    Fogarty C; Goldschmidt R; Bush K
    Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.
    Cunha BA
    Postgrad Med; 2003 Jan; 113(1):42-4, 47-8, 52-4. PubMed ID: 12545592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attacking the pneumococcus -- a hundred years' war.
    Swartz MN
    N Engl J Med; 2002 Mar; 346(10):722. PubMed ID: 11882726
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
    Lee WK; Young BW
    J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
    [No Abstract]   [Full Text] [Related]  

  • 13. Levofloxacin failure in a patient with pneumococcal pneumonia.
    Empey PE; Jennings HR; Thornton AC; Rapp RP; Evans ME
    Ann Pharmacother; 2001 Jun; 35(6):687-90. PubMed ID: 11408985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
    Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
    BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Tillotson GS; Zhao X; Drlica K
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102062
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Hutchinson J
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102064
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of resistance to levofloxacin of Streptococcus pneumoniae following fluoroquinolone therapy.
    d'Escrivan T; Roussel-Delvallez M; Alfandari S; Guery B
    Infection; 2003 Oct; 31(5):366. PubMed ID: 14556066
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
    Soriano F
    Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.